Latest The Texas Heart Institute Stories
BELGRADE, Serbia, October 16 /PRNewswire/ -- - Clinical Trial Designed to Evaluate the Ability of Cardio3Biosciences' C-Cure(R) to Restore Heart Function Clinical Center of Serbia, Institute for Cardiovascular Diseases today announced that it has treated its first patient with a revolutionary cell-based therapy for heart failure. The patient is participating in an international trial of C-Cure(R), a second generation cell therapy developed by Cardio3 BioSciences, a leading...
FRAMINGHAM, Mass. and SYDNEY, Aug. 20 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR - ASX: HIN) today announced that HeartWare has surpassed 50 implants in the United States under its ADVANCE Clinical Trial, marking an important early enrollment milestone. The 50th implant in the US was performed last week at the Texas Heart Institute in Houston, Texas by O.H. Frazier, MD a distinguished surgeon, scientist, and academician renowned for his research and development...
DALLAS, July 22 /PRNewswire-USNewswire/ -- Texas Health Presbyterian Hospital Dallas has been recognized by the American Heart Association for providing quality, evidence-based care for coronary artery disease and heart failure."This is another example of the dedication and commitment in providing stellar quality heart and vascular care to the Dallas community by physicians, nursing, allied health professionals and administration," said Jon Gardner, administrative director of the Heart...
Structural cardiovascular abnormalities present at birth are the leading cause of heart failure in children. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.The July issue of the journal Pediatric Cardiology focuses on a recent meeting of pediatric cardiology experts...
IRVINE, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Cardiogenesis Corporation (Pink Sheets: CGCP), a global leader of innovative therapies for ischemic cardiac disease and the market leader of surgical products for transmyocardial revascularization (TMR), sponsored an educational symposium yesterday in conjunction with the 20th Annual Transcatheter Cardiovascular Therapeutics (TCT) meeting in Washington, D.C. The symposium, titled "New Horizons in Cardiac Regenerative Medicine: Advancements...
LAKE FOREST, Calif., Sept. 15 /PRNewswire/ -- Orqis(R) Medical Corporation announced the first implant of the new Exeleras System in a 47 year old man suffering from NYHA Class III heart failure. The man was a moderately severe heart failure patient who, without the Exeleras device, would need to decline significantly to be considered a candidate for a more invasive ventricular assist device procedure. Within 48 hours of the minimally invasive Exeleras procedure being performed, the...
By Todd Ackerman, Houston Chronicle Jul. 27--When he was a sophomore in high school, Jim Willerson's parents decided it would be a treat for their son to meet Dr. Denton Cooley, then a rising star coming to San Antonio to lecture on heart surgery. Despite the aspiring doctor's protestations, they deposited him in a station wagon with four physicians who picked Cooley up at the airport, then proceeded to one's home. Willerson had never met any of them. "I thought it was the silliest thing...
By The Dallas Morning News Jul. 13--Michael DeBakey, the father of modern cardiovascular surgery who invented scores of medical procedures and instruments, developed the Mobile Army Surgical Hospital and established what later became the Veterans Administration hospital system, died Friday. He was 99. Dr. DeBakey died at The Methodist Hospital in Houston of natural causes, according to a statement issued early Saturday by the hospital and Baylor. "His legacy is holding the fragile and...
By John Porretto HOUSTON -- When Dr. Michael E. DeBakey pushed forward with his groundbreaking research and maverick approach to medicine a half century ago, heart surgery was a medical marvel. Today, in part because of his contributions, it routinely saves thousands of lives each day. DeBakey, a world-famous cardiovascular surgeon who pioneered such now-common procedures as bypass surgery and invented a host of devices to help heart patients, died Friday night in Houston. He was 99....
BRENTWOOD, Tenn., Feb. 25, 2008 (PRIME NEWSWIRE) -- Imagine a life-saving heart test from a non-invasive device that uses no catheters, no needles, and no blood. A Brentwood, Tenn., company not only imagined it -- they created it and industry analysts now say it could become the future standard of care. The FloWave 1000, one of a mere handful of medical devices created in this Nashville-TN region so rich in healthcare, is actually a medical miracle in its own right after securing clinical...
